Old Web
English
Sign In
Acemap
>
Paper
>
Corrigendum to ‘VP1-2021: Efficacy of everolimus in patients with HR+/HER2- high risk early stage breast cancer’
Corrigendum to ‘VP1-2021: Efficacy of everolimus in patients with HR+/HER2- high risk early stage breast cancer’
2021
Thomas Bachelot
Florence Dalenc
Sylvie Chabaud
Ph Cottu
D. Allouache
E. Brain
J-P Jacquin
J. Grenier
L. Venat Bouvet
M. Brunt
Mario Campone
F. Del Piano
Marc Debled
A-C. Hardy-Bessard
Sylvie Giacchetti
Judith M. Bliss
J. L. Canon
Jérome Lemonnier
D. Cameron
F. André
Keywords:
Breast cancer
Internal medicine
in patient
Stage (cooking)
Oncology
Medicine
Everolimus
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]